| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Access to cancer care for undocumented immigrants in the USA
|
Santos, Patricia Mae G
|
|
|
26 |
8 |
p. e448-e457
|
artikel
|
| 2 |
Belantamab mafodotin plus bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): updated overall survival analysis from a global, randomised, open-label, phase 3 trial
|
Hungria, Vania
|
|
|
26 |
8 |
p. 1067-1080
|
artikel
|
| 3 |
Cancer clinical trials should capture tobacco smoking status
|
Evans, William K
|
|
|
26 |
8 |
p. 990-993
|
artikel
|
| 4 |
Cancer drug discovery at warp speed: can AI deliver?
|
The Lancet Oncology,
|
|
|
26 |
8 |
p. 981
|
artikel
|
| 5 |
Carcinogenicity of hepatitis D virus, human cytomegalovirus, and Merkel cell polyomavirus
|
Karagas, Margaret R
|
|
|
26 |
8 |
p. 994-995
|
artikel
|
| 6 |
Correction to Lancet Oncol 2025; 26: 771–80
|
|
|
|
26 |
8 |
p. e412
|
artikel
|
| 7 |
CRISPR-engineered T-cell therapies: some clarifications needed
|
Palaz, Fahreddin
|
|
|
26 |
8 |
p. e403
|
artikel
|
| 8 |
CRISPR-engineered T-cell therapies: some clarifications needed
|
Huang, Jinbang
|
|
|
26 |
8 |
p. e404
|
artikel
|
| 9 |
CRISPR-engineered T-cell therapies: some clarifications needed – Authors' reply
|
Webber, Beau R
|
|
|
26 |
8 |
p. e405-e406
|
artikel
|
| 10 |
Decoding the genomic landscape of early-onset colorectal cancer: the next chapter in precision oncology
|
Seeber, Andreas
|
|
|
26 |
8 |
p. 987-988
|
artikel
|
| 11 |
Derivation and validation of the AJCC9V pathological stage classification for HPV-positive oropharyngeal carcinoma: a multicentre registry analysis
|
Ho, Allen S
|
|
|
26 |
8 |
p. 1113-1122
|
artikel
|
| 12 |
Epithelioid sarcoma presenting as a progressively enlarging wound
|
Tsai, Yu-Ting
|
|
|
26 |
8 |
p. e458
|
artikel
|
| 13 |
ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma: update 2025
|
Concin, Nicole
|
|
|
26 |
8 |
p. e423-e435
|
artikel
|
| 14 |
FDA gives import exemptions to drugs made in banned factories
|
Devi, Sharmila
|
|
|
26 |
8 |
p. 998
|
artikel
|
| 15 |
Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: a secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trial
|
Ferdinandus, Justin
|
|
|
26 |
8 |
p. 1081-1090
|
artikel
|
| 16 |
First-in-human results of terbium-161 [161Tb]Tb-PSMA-I&T dual beta–Auger radioligand therapy in patients with metastatic castration-resistant prostate cancer (VIOLET): a single-centre, single-arm, phase 1/2 study
|
Buteau, James P
|
|
|
26 |
8 |
p. 1009-1017
|
artikel
|
| 17 |
Government action on cancer deaths that cost the UK economy £10·3 billion per year
|
Gourd, Elizabeth
|
|
|
26 |
8 |
p. 1000
|
artikel
|
| 18 |
HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysis
|
Villacampa, Guillermo
|
|
|
26 |
8 |
p. 1100-1112
|
artikel
|
| 19 |
Improved prognostication of surgically treated patients with HPV-positive oropharyngeal carcinoma
|
Dietz, Andreas
|
|
|
26 |
8 |
p. 988-990
|
artikel
|
| 20 |
Launch of a 10-Year Health Plan for England
|
Burki, Talha
|
|
|
26 |
8 |
p. 1004
|
artikel
|
| 21 |
Long-term survival and cure fraction estimates for paediatric central nervous system tumours in 31 European countries (EUROCARE-6): a population-based study
|
Hoogendijk, Raoull
|
|
|
26 |
8 |
p. 1091-1099
|
artikel
|
| 22 |
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol
|
Gillessen, Silke
|
|
|
26 |
8 |
p. 1018-1030
|
artikel
|
| 23 |
Metformin in prostate cancer
|
Gebrael, Georges
|
|
|
26 |
8 |
p. 982-983
|
artikel
|
| 24 |
Neurotoxicity-related treatment discontinuations in PRODIGE 51-FFCD-GASTFOX
|
Tuzcu, Tuba Uğur
|
|
|
26 |
8 |
p. e401
|
artikel
|
| 25 |
Neurotoxicity-related treatment discontinuations in PRODIGE 51-FFCD-GASTFOX – Authors' reply
|
Zaanan, Aziz
|
|
|
26 |
8 |
p. e402
|
artikel
|
| 26 |
New legislation set to improve drug access for American patients with cancer
|
Gruber, Karl
|
|
|
26 |
8 |
p. 1002
|
artikel
|
| 27 |
New national cancer registry for France
|
Casassus, Barbara
|
|
|
26 |
8 |
p. 999
|
artikel
|
| 28 |
Oral contraceptives and risk of liver cancer
|
Iversen, Lisa
|
|
|
26 |
8 |
p. 983-985
|
artikel
|
| 29 |
Oral contraceptive use and risk of liver cancer: a population-based study, systematic review, and meta-analysis
|
Watling, Cody Z
|
|
|
26 |
8 |
p. 1031-1042
|
artikel
|
| 30 |
Patterns in genomic mutations among patients with early-onset colorectal cancer: an international, multicohort, observational study
|
Li, Jinming
|
|
|
26 |
8 |
p. 1055-1066
|
artikel
|
| 31 |
Reflections on the PEACE V–STORM trial
|
Fiorica, Francesco
|
|
|
26 |
8 |
p. e407
|
artikel
|
| 32 |
Reflections on the PEACE V–STORM trial
|
Quarta, Leonardo
|
|
|
26 |
8 |
p. e408
|
artikel
|
| 33 |
Reflections on the PEACE V–STORM trial
|
Aluwini, Shafak
|
|
|
26 |
8 |
p. e409
|
artikel
|
| 34 |
Reflections on the PEACE V–STORM trial – Authors' reply
|
Ost, Piet
|
|
|
26 |
8 |
p. e410-e411
|
artikel
|
| 35 |
The fight against burnout: doctors in distress
|
Efthymiou, Paul
|
|
|
26 |
8 |
p. 1007-1008
|
artikel
|
| 36 |
Therapeutic geographies of cancer in conflict: cancer care in Iraq
|
Skelton, Mac
|
|
|
26 |
8 |
p. e414-e422
|
artikel
|
| 37 |
Total neoadjuvant therapy with immunotherapy in locally advanced rectal cancer
|
Kanani, Arezo
|
|
|
26 |
8 |
p. 985-987
|
artikel
|
| 38 |
Total neoadjuvant treatment with short-course radiotherapy followed by sintilimab plus capecitabine–oxaliplatin versus short-course radiotherapy followed by capecitabine–oxaliplatin in patients with locally advanced rectal cancer (SPRING-01): a single-centre, open-label, phase 2, randomised controlled trial
|
Tian, Feng
|
|
|
26 |
8 |
p. 1043-1054
|
artikel
|
| 39 |
UK House of Commons passes assisted dying bill
|
Burki, Talha
|
|
|
26 |
8 |
p. 997
|
artikel
|
| 40 |
Unpublished overall survival confounders in immunomodulatory agent registrational trials
|
Lindberg, Jakob
|
|
|
26 |
8 |
p. e398-e399
|
artikel
|
| 41 |
Unpublished overall survival confounders in immunomodulatory agent registrational trials – Authors' reply
|
San-Miguel, Jesus
|
|
|
26 |
8 |
p. e400
|
artikel
|
| 42 |
Update to the RANO working group and EANO recommendations for the clinical use of PET imaging in gliomas
|
Galldiks, Norbert
|
|
|
26 |
8 |
p. e436-e447
|
artikel
|
| 43 |
US cancer research might never recover from proposed Trump funding cuts
|
Kirby, Tony
|
|
|
26 |
8 |
p. 1001
|
artikel
|
| 44 |
US mRNA cancer vaccine research faces an uncertain future
|
Furlow, Bryant
|
|
|
26 |
8 |
p. e413
|
artikel
|
| 45 |
Who is responsible for cancer survivorship care?
|
Lustberg, Maryam B
|
|
|
26 |
8 |
p. 1005-1006
|
artikel
|
| 46 |
WHO launches 10th report on the global tobacco epidemic
|
Samarasekera, Udani
|
|
|
26 |
8 |
p. 996
|
artikel
|
| 47 |
WHO's 3 by 35 initiative
|
Das, Manjulika
|
|
|
26 |
8 |
p. 1003
|
artikel
|
Tijdschrift beschrijving